Identifying the right patient for Zytiga (Abiraterone) or Xtandi (Enzalutamide)

Christopher J. Logothetis, MD of MD Anderson Cancer Center discusses how he identifies and chooses the right patients for abiraterone and enzalutamide at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/21/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts